- Investigator
- Mark S Segal
- Status
- Accepting Candidates
Research at a glance
Top areas of exploration
- Cells, Cultured , 19 publications
- Biomarkers , 17 publications
- Kidney Failure, Chronic , 16 publications
- Hypertension , 16 publications
Research activity
Active clinical trials
The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and delivered percutaneously into biopsied and non-biopsied contralateral kidneys in participants with鈥�
- Investigator
- Mark S Segal
- Status
- Accepting Candidates
- Ages
- 30 Years - 80 Years
- Sexes
- All
- Investigator
- Mark S Segal
- Status
- Accepting Candidates
My publications
Filter publications
161 publications
2025
Association Between Use of WATCHMAN Device and 1-Year Mortality Using High-Dimensional Propensity Scores to Reduce Confounding.
Circulation. Cardiovascular quality and outcomes
鈥�2025
Epidemiology, trajectories and outcomes of acute kidney injury among hospitalized patients: a large retrospective multicenter cohort study.
Journal of nephrology
鈥�2024
Altered lipid homeostasis and autophagy precipitate diffuse alveolar hemorrhage in murine lupus.
Autophagy reports
鈥�2024
Development and validation of a race-agnostic computable phenotype for kidney health in adult hospitalized patients.
PloS one
鈥�2024
Ethics and Terminology for Opting In and Out.
JAMA internal medicine
鈥�